| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | X | Z |
| | | IP | CI | A | MST Continus 10 mg
Tabletten retard - T | 60 Tablet(s) | 13.83 | 28.20 | 10 % | | | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A / SL | FB | | G |  |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 20 ml | 6.85 | 16.05 | 10 % | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | A / SL | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 20
mg/ml | 20 ml | 11.64 | 25.65 | 10 % | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 20 mg/ml | Streuli Pharma AG | A / SL | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 50 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 20
mg/ml | 50 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Morphini Hydrochloridum Trihydricum 20 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
1mg/ml | 20 1 Sachet(s) à 100 ml | PR | PR | k.A. | | soluzione per infusione: Morphini Sulfas Pentahydricus 1 mg/ml | Sintetica SA | A | FB | | G | |
| | | IP | CI | A | Medikinet 5 mg | 20 Tablet(s) | 2.16 | 11.60 | 10 % | | Tablets: Methylphenidati Hydrochloridum 5 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Medikinet 5 mg | 50 Tablet(s) | 4.75 | 14.40 | 10 % | | Tablets: Methylphenidati Hydrochloridum 5 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Medikinet 10 mg | 20 Tablet(s) | 3.54 | 13.10 | 10 % | | Tablets: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Medikinet 10 mg | 50 Tablet(s) | 7.79 | 17.70 | 10 % | | Tablets: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Medikinet 20 mg | 20 Tablet(s) | 6.04 | 15.80 | 10 % | | Tablets: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Medikinet 20 mg | 50 Tablet(s) | 13.29 | 30.85 | 10 % | | Tablets: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ / SL / SG | FB | | G | |
| | | IP | CI | A | Makatussin Comp. | 80 ml | 3.70 | 13.25 | 10 % | | Sirup: 2 Active Agents | Gebro Pharma AG | B / SL | FB | | G | |
| | | IP | CI | A | MST Continus 30 mg - T | 60 Tablet(s) | 31.27 | 50.40 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 30 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 60 mg - T | 30 Tablet(s) | 26.87 | 45.65 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 60 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 100 mg - T | 30 Tablet(s) | 42.77 | 62.95 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 100 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | MST Continus 200 mg - T | 30 Tablet(s) | 62.27 | 84.15 | 10 % | | Delayed release tablets: Morphini Sulfas Pentahydricus 200 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 10 mg | 50 Capsule(s) | 21.08 | 39.35 | 10 % | | Capsules: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 10 mg | 100 Capsule(s) | 37.10 | 56.75 | 10 % | | Capsules: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 20 mg | 50 Capsule(s) | 34.57 | 54.00 | 10 % | | Capsules: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 20 mg | 100 Capsule(s) | 60.85 | 82.60 | 10 % | | Capsules: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 30 mg | 50 Capsule(s) | 65.18 | 87.30 | 10 % | | Capsules: Methylphenidati Hydrochloridum 30 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 30 mg | 100 Capsule(s) | 108.85 | 134.80 | 10 % | | Capsules: Methylphenidati Hydrochloridum 30 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 40 mg | 50 Capsule(s) | 79.21 | 102.55 | 10 % | | Capsules: Methylphenidati Hydrochloridum 40 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Medikinet MR 40 mg | 100 Capsule(s) | 139.41 | 168.05 | 10 % | | Capsules: Methylphenidati Hydrochloridum 40 mg | Salmon Pharma GmbH | A+ / SL | FB | | G | |
| | | IP | CI | A | Methadon Streuli - T | 20 Tablet(s) | 1.80 | 11.20 | 10 % | | Tablets: Methadoni Hydrochloridum 5 mg | Streuli Pharma AG | A+ / SL | FB | | G | |
| | | IP | CI | A | Mogadon - T | 10 Tablet(s) | 1.82 | 11.20 | 10 % | | Tablets: Nitrazepamum 5 mg | MEDA Pharmaceuticals
Switzerland GmbH | B / SL | FB | | G | |
| | | IP | CI | A | Mogadon - T | 50 Tablet(s) | 7.26 | 17.15 | 10 % | | Tablets: Nitrazepamum 5 mg | MEDA Pharmaceuticals
Switzerland GmbH | B / SL | FB | | G | |
| | | IP | CI | A | Makatussin | 30 g | 5.82 | 15.55 | 10 % | | Drops: Codeini Phosphas Hemihydricus 13.6 mg/g | Gebro Pharma AG | B / SL | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 100 ml | 10.80 | 28.15 | 10 % | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A+ / SL | FB | | G | |
| | | IP | | A | Methadon Sintetica 10 mg | 10 1 ampoule(s) à 1 ml | PR | PR | k.A. | | Injection solution: Methadoni Hydrochloridum 10 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Midazolam Sintetica 2
mg/2 ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 2mg / 2ml | Sintetica SA | B | FB | | G | |
| | | IP | | A | Midazolam Sintetica 5
mg/5 ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 5mg / 5ml | Sintetica SA | B | FB | | G | |
| | | IP | | A | Midazolam Sintetica 15
mg/3 ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 15mg / 3ml | Sintetica SA | B | FB | | G | |
| | | IP | | A | Midazolam Sintetica 5
mg/1ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | A | Midazolam Sintetica 50
mg/10 ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 50mg / 10ml | Sintetica SA | B | FB | | G | |
| | | IP | | A | Morphin HCl 0,2 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 0,4 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 1 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 1 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCI 2 mg/ml
Bichsel | 10 Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 2 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl 10 mg/ml
Bichsel | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Laboratorium Dr. G.
Bichsel AG | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 2
mg/2 ml | 10 1 ampoule(s) à 2 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 2mg / 2ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 5
mg/0.5ml | 10 1 ampoule(s) à 0.5 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 5mg / 0.5ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 10
mg/1 ml | 10 1 ampoule(s) à 1 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin HCl Sintetica 100
mg/10 ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 100mg / 10ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
10mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 10 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
50mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 50 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphin Sulfate Sintetica
50mg/ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Morphini Sulfas Pentahydricus 50 mg/ml | Sintetica SA | A+ | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | ● A+ | FB | | G | |
| | | IP | | A | Morphini HCl Streuli 10
mg/ml | 100 ampoule(s) | PR | PR | k.A. | | Injection solution: Morphini Hydrochloridum Trihydricum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 12 ug/h | 5 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 1.38 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 12 ug/h | 10 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 1.38 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 25 ug/h | 5 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 2.75 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 25 ug/h | 10 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 2.75 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 50 ug/h | 5 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 5.5 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 50 ug/h | 10 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 5.5 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 75 ug/h | 5 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 8.25 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 75 ug/h | 10 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 8.25 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 100 ug/h | 5 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 11 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Matrifen 100 ug/h | 10 plaster(s) | PR | PR | k.A. | | Transdermal System: Fentanylum 11 mg | Takeda Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Medikinet MR 10 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet MR 20 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet MR 30 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Methylphenidati Hydrochloridum 30 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet MR 40 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Methylphenidati Hydrochloridum 40 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet 5 mg | 100 Tablet(s) | PR | PR | k.A. | | Tablets: Methylphenidati Hydrochloridum 5 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet 10 mg | 100 Tablet(s) | PR | PR | k.A. | | Tablets: Methylphenidati Hydrochloridum 10 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Medikinet 20 mg | 100 Tablet(s) | PR | PR | k.A. | | Tablets: Methylphenidati Hydrochloridum 20 mg | Salmon Pharma GmbH | A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli - T | 100 Tablet(s) | PR | PR | k.A. | | Tablets: Methadoni Hydrochloridum 5 mg | Streuli Pharma AG | ● A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli | 10 ampoule(s) | PR | PR | k.A. | | Injektionslösung (s.c., i.m., i.v.): Methadoni Hydrochloridum 10 mg | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli | 100 ampoule(s) | PR | PR | k.A. | | Injektionslösung (s.c., i.m., i.v.): Methadoni Hydrochloridum 10 mg | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 500 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | CI | A | Methadon Streuli 10 mg/ml | Flasche(n) à 1000 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A+ | FB | | G | |
| | | IP | | A | Midazolam Actavis 5 mg / 1 ml | 5 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 5 mg/ml | Mepha Pharma AG | B | FB | | G | |
| | | IP | | A | Midazolam Actavis 5 mg / 1 ml | 5 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 5 mg/ml | Mepha Pharma AG | B | FB | | G | |
| | | IP | | A | Midazolam Actavis 5 mg / 1 ml | 5 x 5 ampoule(s) | PR | PR | k.A. | | Injection solution: Midazolamum 5 mg/ml | Mepha Pharma AG | B | FB | | G | |
